Anomalía cíclica alrededor de un agujero negro, satélite BurstCube, deformación en un asteroide
Noticias de la actualidad astronómica y astronáutica del 8 de abril de 2024. …
Uncategorized
Deepening the Partnership: Dawn Health Introduces Ekiva for Enhanced Disease Management of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Building upon their partnership announced last year, digital health leader Dawn Health and global pharmaceutical company Novartis are proud to announce the launch of Ekiva PNH, an innovative digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria.
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
Calliditas Therapeutics AB announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office for patent application no. 16/760,910 entitled “Use of NOX Inhibitors for Treatment of Cancer”.
¿Cómo se forman los brazos en las galaxias espirales?
Las galaxias espirales son una de las estructuras más fascinantes y hermosas del universo, caracterizadas por sus brillantes brazos espirales que se curvan elegantemente alrededor de un núcleo central. Durante décadas, los astrónomos han debatido sobre el origen y la form …
¿Cómo se forman los brazos en las galaxias espirales? Read More »
Las fases de Venus
Entre las maravillas del cosmos, pocas rivalizan en belleza y misterio con las fases cambiantes de Venus, nuestro vecino planetario más brillante. Desde la antigüedad, los astrónomos han observado con asombro cómo Venus exhibe una variedad de formas en su apariencia a lo la …
AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting
Ascentage Pharma announced that it releases the latest results from three preclinical studies of its novel drug candidates olverembatinib, MDM2-p53 inhibitor alrizomadlin, FAK/ALK/ROS1 tyrosine kinase inhibitor APG-2449, and embryonic ectoderm development inhibitor APG-5918, at the 2024 American Association of Cancer Research Annual Meeting.
ViroCell to present at 2024 Cell & Gene Meeting on the Med
ViroCell Biologics announces that John W. Hadden II, Chief Executive Officer, will be presenting at the annual Cell & Gene Meeting on the Med to be held April 9-11 in Rome, Italy.
ViroCell to present at 2024 Cell & Gene Meeting on the Med Read More »
Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates at AACR 2024
Laekna announced that the company has presented two internally-discovered preclinical candidates, in addition to a poster presentation on a clinical trial, at the 2024 Annual Meeting of the American Association for Cancer Research in San Diego, California.
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module
Boston Scientific Corporation has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize and track the FARAWAVE™ Nav Pulsed Field Ablation Catheter* for the treatment of patients with paroxysmal and persistent atrial fibrillation.
Renalys Pharma Submits an IND Application for a Phase III Clinical Trial of sparsentan for IgA Nephropathy in Japan
Renalys Pharma, Inc. announced that it has submitted an Investigational New Drug Application for sparsentan to the Pharmaceuticals and Medical Devices Agency for a Phase III clinical trial in Japan.